Fingerprint
Dive into the research topics of 'Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer
Sushil K. Badrising, Vincent van der Noort, Paul Hamberg, Jules L. L. M. Coenen, Maureen J. Aarts, Inge M. van Oort, Alfons J. M. van den Eertwegh, Maartje Los, H. Pieter van den Berg, Hans Gelderblom, Suzan Vrijaldenhoven, Emile D. Kerver, Theo van Voorthuizen, Igle J. de Jong, John B. Haanen, Andries M. Bergman*, Dutch Uro-Oncol Study Grp DUOS
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
11
Citations
(Scopus)